Allurion Technologies (ALUR) Competitors $2.96 -0.22 (-6.76%) Closing price 03:57 PM EasternExtended Trading$2.96 0.00 (-0.17%) As of 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALUR vs. VANI, ZYXI, NVNO, NSPR, CTSO, MDAI, SURG, HYPR, EDAP, and ICCMShould you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include Vivani Medical (VANI), Zynex (ZYXI), enVVeno Medical (NVNO), InspireMD (NSPR), Cytosorbents (CTSO), Spectral AI (MDAI), SurgePays (SURG), Hyperfine (HYPR), EDAP TMS (EDAP), and IceCure Medical (ICCM). These companies are all part of the "medical equipment" industry. Allurion Technologies vs. Its Competitors Vivani Medical Zynex enVVeno Medical InspireMD Cytosorbents Spectral AI SurgePays Hyperfine EDAP TMS IceCure Medical Allurion Technologies (NYSE:ALUR) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation. Do analysts rate ALUR or VANI? Allurion Technologies currently has a consensus target price of $22.83, indicating a potential upside of 670.10%. Vivani Medical has a consensus target price of $4.00, indicating a potential upside of 146.91%. Given Allurion Technologies' higher possible upside, analysts plainly believe Allurion Technologies is more favorable than Vivani Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Allurion Technologies 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Vivani Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is ALUR or VANI more profitable? Vivani Medical has a net margin of 0.00% compared to Allurion Technologies' net margin of -86.05%. Allurion Technologies' return on equity of 0.00% beat Vivani Medical's return on equity.Company Net Margins Return on Equity Return on Assets Allurion Technologies-86.05% N/A -41.49% Vivani Medical N/A -133.07%-56.50% Do insiders & institutionals believe in ALUR or VANI? 21.4% of Allurion Technologies shares are held by institutional investors. Comparatively, 6.8% of Vivani Medical shares are held by institutional investors. 22.4% of Allurion Technologies shares are held by company insiders. Comparatively, 46.4% of Vivani Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has higher earnings & valuation, ALUR or VANI? Vivani Medical has lower revenue, but higher earnings than Allurion Technologies. Vivani Medical is trading at a lower price-to-earnings ratio than Allurion Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAllurion Technologies$28.30M0.78-$26.15M-$12.50-0.24Vivani MedicalN/AN/A-$23.49M-$0.43-3.77 Which has more risk & volatility, ALUR or VANI? Allurion Technologies has a beta of -0.47, suggesting that its stock price is 147% less volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.89, suggesting that its stock price is 189% more volatile than the S&P 500. Does the media prefer ALUR or VANI? In the previous week, Allurion Technologies had 3 more articles in the media than Vivani Medical. MarketBeat recorded 4 mentions for Allurion Technologies and 1 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 1.87 beat Allurion Technologies' score of 0.54 indicating that Vivani Medical is being referred to more favorably in the news media. Company Overall Sentiment Allurion Technologies Positive Vivani Medical Very Positive SummaryAllurion Technologies beats Vivani Medical on 9 of the 15 factors compared between the two stocks. Get Allurion Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALUR vs. The Competition Export to ExcelMetricAllurion TechnologiesMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$22.11M$10.23B$5.57B$20.65BDividend YieldN/A2.09%4.23%3.65%P/E Ratio-0.2416.9728.6127.29Price / Sales0.7829.08412.0053.17Price / CashN/A22.6736.0222.28Price / Book-0.103.598.234.60Net Income-$26.15M$233.40M$3.23B$995.22M7 Day Performance3.67%-2.69%-0.01%-0.80%1 Month Performance20.53%1.85%5.61%3.55%1 Year Performance-88.14%-18.53%26.52%7.35% Allurion Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALURAllurion Technologies2.9648 of 5 stars$2.97-6.8%$22.83+670.1%-87.4%$22.11M$28.30M-0.24501VANIVivani Medical3.4131 of 5 stars$1.27+0.8%$4.00+215.0%+14.3%$74.65MN/A-2.9520Positive NewsZYXIZynex2.0392 of 5 stars$2.51+4.6%$6.00+139.0%-75.7%$72.57M$192.35M-10.46770Upcoming EarningsAnalyst ForecastNVNOenVVeno Medical0.6347 of 5 stars$3.93-1.5%N/A-33.3%$69.97MN/A-3.3330NSPRInspireMD2.7732 of 5 stars$2.22-0.9%$4.50+102.7%-5.3%$68.62M$7.03M-2.9650High Trading VolumeCTSOCytosorbents1.5514 of 5 stars$1.03-5.5%$5.50+434.0%-3.7%$68.25M$35.60M-3.68220MDAISpectral AI3.5482 of 5 stars$2.72+1.5%$4.75+74.6%+51.9%$67.85M$29.58M-5.0483SURGSurgePays3.1661 of 5 stars$3.30+1.9%$9.00+172.7%-3.3%$66.14M$40.03M-1.1840HYPRHyperfine3.137 of 5 stars$0.77-4.4%$1.06+38.6%-24.1%$62.27M$12.89M-1.42190Positive NewsEDAPEDAP TMS3.0463 of 5 stars$1.57-1.3%$8.50+441.4%-70.3%$59.45M$69.18M-2.53230News CoverageAnalyst DowngradeICCMIceCure Medical2.3193 of 5 stars$1.05-0.5%$2.50+138.1%+34.7%$58.56M$3.27M-3.7560Gap Down Related Companies and Tools Related Companies Vivani Medical Competitors Zynex Competitors enVVeno Medical Competitors InspireMD Competitors Cytosorbents Competitors Spectral AI Competitors SurgePays Competitors Hyperfine Competitors EDAP TMS Competitors IceCure Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ALUR) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allurion Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allurion Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALUR Stock Alerts